Shah Capital Pushes for Novavax Sale, Warns of Proxy Fight

(Reuters) -Shah Capital, Novavax's second-largest shareholder, is pressing the biotech's board to pursue strategic changes, ...
Healio

BLOG: Preparing transplant, cellular therapy recipients for the respiratory viral season

The 2025-2026 respiratory viral season is approaching.With it comes the familiar challenge of protecting our most vulnerable ...
TipRanks on MSN

GeoVax Labs: Vaccine Progress Amid Financial Challenges

Geovax Labs, Inc. (($GOVX)) has held its Q3 earnings call. Read on for the main highlights of the call. In the recent earnings call, GeoVax Labs, ...

Biotech and Pharma

Moderna Stock Is Climbing. It Has Been a Tumultuous Few Days for Pharma. Shares of Novavax, Pfizer, and other peers were also seeing gains on Tuesday. Both well-established and small, clinical-stage ...